TY - JOUR
T1 - Carer preparedness improved by providing a supportive educational intervention for carers of patients with high-grade glioma
T2 - RCT results
AU - the Care-IS Project Team
AU - Halkett, Georgia K.B.
AU - Lobb, Elizabeth A.
AU - Phillips, Jane L.
AU - McDougall, Emma
AU - Clarke, Jenny
AU - Campbell, Rachel
AU - Dhillon, Haryana M.
AU - McGeechan, Kevin
AU - Hudson, Peter
AU - King, Anne
AU - Wheeler, Helen
AU - Kastelan, Marina
AU - Long, Anne
AU - Nowak, Anna K.
AU - Newton, Jade
AU - Emery, Laura
AU - Gilbert, Marie
AU - Atwood, Robyn
AU - Miller, Lisa
AU - Agar, Meera
AU - Moorin, Rachael
AU - Shaw, Therese
AU - Bulsara, Max
N1 - Funding Information:
Thank you to the clinicians who recruited and referred participants; Claire Savage, Emily Hepsworth, Linda Ye, Mary Corker, Michelle McMullen, Sanju Kondola, Tim Humphries, Daphne Tsoi, Elizabeth Hovey, Dari Place, Georgia Ritchie, Joyce Bonello, Cecelia Gzell, Subotheni Thavaneswaran, Suzanne McNella, Tracey Dunlop, Kelly Conway, Iris Wong, Stella Lee, Hao-Wen Sim, Brindha Shivalingam and Samantha Bowyer. Thank you Care-IS research team members; who contributed at different stages during the study; Jade Newton, Laura Emery, Marie Gilbert, Robyn Atwood, Lisa Miller, Meera Agar, Rachael Moorin, Therese Shaw and Max Bulsara. We also thank our consumer representatives (Diana Andrew, Anne Wakeling and Kim Peppiatt) and all the patients and carers who participated in the Care-IS trial.
Funding Information:
This project was funded by a Cancer Australia Priority-driven Collaborative Cancer Research Scheme project grant (APP1105307). Data analysis was supported by funding from the Medical Research Future Fund for the Brain cancer Rehabilitation, Assessment, Intervention of survivor NeedS (BRAINS) project. Georgia Halkett is currently supported by a Cancer Council of WA Research Fellowship.
Publisher Copyright:
© 2023, The Author(s).
PY - 2023/2
Y1 - 2023/2
N2 - Background: High-grade glioma (HGG) is a rapidly progressing and debilitating disease. Family carers take on multiple responsibilities and experience high levels of distress. We aimed to deliver a nurse-led intervention (Care-IS) to carers to improve their preparedness to care and reduce distress. Methods: We conducted a randomised controlled trial (ACTRN:12612001147875). Carers of HGG patients were recruited during patients’ combined chemoradiation treatment. The complex intervention comprised four components: (1) initial telephone assessment of carer unmet needs; (2) tailored hard-copy resource folder; (3) home visit; and, (4) monthly telephone support for up to 12 months. Primary outcomes included preparedness for caregiving and distress at 2, 4, 6 and 12 months. Intervention effects were estimated using linear mixed models which included a time by group interaction. Secondary outcomes included anxiety, depression, quality of life, carer competence and strain. Results: We randomised 188 carers (n = 98 intervention, n = 90 control). The intervention group reported significantly higher preparedness for caregiving at 4 months (model β = 2.85, 95% CI 0.76–4.93) and all follow-up timepoints including 12 months (model β = 4.35, 95% CI 2.08–6.62), compared to the control group. However, there was no difference between groups in carer distress or any secondary outcomes. Conclusions: This intervention was effective in improving carer preparedness. However, carer distress was not reduced, potentially due to the debilitating/progressive nature of HGG and ongoing caring responsibilities. Future research must explore whether carer interventions can improve carer adjustment, self-efficacy and coping and how we support carers after bereavement. Additionally, research is needed to determine how to implement carer support into practice.
AB - Background: High-grade glioma (HGG) is a rapidly progressing and debilitating disease. Family carers take on multiple responsibilities and experience high levels of distress. We aimed to deliver a nurse-led intervention (Care-IS) to carers to improve their preparedness to care and reduce distress. Methods: We conducted a randomised controlled trial (ACTRN:12612001147875). Carers of HGG patients were recruited during patients’ combined chemoradiation treatment. The complex intervention comprised four components: (1) initial telephone assessment of carer unmet needs; (2) tailored hard-copy resource folder; (3) home visit; and, (4) monthly telephone support for up to 12 months. Primary outcomes included preparedness for caregiving and distress at 2, 4, 6 and 12 months. Intervention effects were estimated using linear mixed models which included a time by group interaction. Secondary outcomes included anxiety, depression, quality of life, carer competence and strain. Results: We randomised 188 carers (n = 98 intervention, n = 90 control). The intervention group reported significantly higher preparedness for caregiving at 4 months (model β = 2.85, 95% CI 0.76–4.93) and all follow-up timepoints including 12 months (model β = 4.35, 95% CI 2.08–6.62), compared to the control group. However, there was no difference between groups in carer distress or any secondary outcomes. Conclusions: This intervention was effective in improving carer preparedness. However, carer distress was not reduced, potentially due to the debilitating/progressive nature of HGG and ongoing caring responsibilities. Future research must explore whether carer interventions can improve carer adjustment, self-efficacy and coping and how we support carers after bereavement. Additionally, research is needed to determine how to implement carer support into practice.
KW - Caregivers
KW - Carer distress
KW - Carer preparedness
KW - High grade glioma
KW - Nurse-led intervention
KW - Randomised controlled trial
UR - http://www.scopus.com/inward/record.url?scp=85146609128&partnerID=8YFLogxK
U2 - 10.1007/s11060-023-04239-0
DO - 10.1007/s11060-023-04239-0
M3 - Article
C2 - 36658381
AN - SCOPUS:85146609128
SN - 0167-594X
VL - 161
SP - 501
EP - 513
JO - Journal of Neuro-Oncology
JF - Journal of Neuro-Oncology
IS - 3
ER -